You just read:

Sysmex Inostics' OncoBEAM™ Liquid Biopsy Technology Demonstrates Utility for Clinical Management of Melanoma Patients Undergoing Treatment With Targeted Therapy and Immune Checkpoint Inhibitors

News provided by

Sysmex Inostics GmbH

15 Oct, 2018, 11:40 BST